ICD-10-CM Billable Code

Z85.79

Personal history of other malignant neoplasms of lymphoid, hematopoietic and related tissues

Clinical Classification Guidelines

Inclusion Terms

  • Conditions classifiable to C88-C90, C96

Excludes Type 1

  • multiple myeloma in remission (C90.01)
  • plasma cell leukemia in remission (C90.11)
  • plasmacytoma in remission (C90.21)

Medical Intelligence & Overview

ICD-10 code Z85.79 refers to a patient's personal history of other malignant neoplasms involving lymphoid, hematopoietic, and related tissues. This classification is designated for individuals who have previously been diagnosed with certain types of cancers affecting immune system tissues, including lymphomas and other blood-related cancers. Recognizing this history is essential for ongoing healthcare management, surveillance, and treatment planning. It is important to note that this code covers conditions classified under the broader categories of C88-C90 and C96, which include various lymphoid and hematopoietic neoplasms.

Causes & Symptoms

Clinical Causes: Genetic mutations leading to abnormal growth of lymphoid or hematopoietic cells Environmental exposures such as radiation or certain chemicals Chronic immune system stimulation or autoimmune conditions Previous oncologic treatments that may influence mutation risk Family history of hematologic cancers

Key Symptoms: Unexplained weight loss Night sweats Persistent fatigue or weakness Swollen lymph nodes in the neck, underarms, or groin Frequent infections or unusual bleeding Fever without an apparent cause Pain or discomfort in affected areas

Diagnostic & Treatment

Diagnosis Path: Diagnosing a personal history of lymphoid or hematopoietic neoplasms typically involves reviewing patient medical history, including prior cancer diagnoses and treatments. Diagnostic procedures may include: - Physical examinations focusing on lymph nodes and organs - Blood tests to assess blood cell counts and general health status - Imaging studies such as CT scans, PET scans, or X-rays to identify residual or recurrent disease - Bone marrow biopsies to evaluate marrow involvement - Histopathological analysis of biopsy samples to determine specific cancer subtype The documentation of such a history in medical records helps guide future monitoring and interventions.

Treatment Protocols: While a history of these malignancies indicates previous treatment, ongoing management depends on current health status and any recurrence. Typical approaches include: - Regular monitoring through blood tests and imaging studies - Maintenance therapies if indicated - Supportive care to manage symptoms and improve quality of life - Counseling and targeted interventions based on the specific type and stage of the prior neoplasm Treatment strategies may evolve with new medical advancements, and personalized plans are developed considering the patient’s past diagnosis and overall health.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is Z85.79 a billable ICD-10 code?
Yes, Z85.79 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report Z85.79?
Clinical documentation must specify the nature of Personal history of other malignant neoplasms of lymphoid, hematopoietic and related tissues and any associated comorbidities for accurate reporting.

Cite this Clinical Reference